2m 2m 2m 2m 2m 2m 2m
Viatris (VTRS)
NASDAQ
$17.63+$0.17 (+0.97%)
Price as of Oct 02, 2026 4:15 PM EDT- $20.1BMarket Cap
- 78.82%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Viatris (VTRS)
$17.63+$0.17 (+0.97%)
VTRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.46 | ||
Change | -$0.26 (-1.47%) | ||
Open | $17.62 | ||
High | $17.84 | ||
Low | $17.43 | ||
Previous Close | $17.72 | ||
Volume | 9,038,825 | ||
30-Day Average Volume | 8,883,679 | ||
1-Week Change | 0.23% | ||
1-Month Change | 4.99% | ||
1-Year Change | 78.82% | ||
3-Year Change | 100.86% | ||
5-Year Change | 58.43% | ||
Fundamentals | |||
Shares Outstanding | 1.1B | ||
Total Assets | $35.0B | ||
Market Cap | $20.1B | ||
Enterprise Value | $32.5B | ||
Period: QTR TTM FY | |||
Revenue | $3.8B | ||
Net Income | -$118.8M | ||
Free Cash Flow | $329.0M | ||
EBIT | $56.7M | ||
EBITDA | $729.0M | ||
Net Working Capital | $3.7B | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | 45 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 1 | ||
P/E | -175 | ||
PEG | 1 | ||
Price/Free Cash Flow | 61 | ||
Price/Operating Cash Flow | 53 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.75% | ||
Trailing Annual Dividend Yield | 2.75% | ||
Ex-Dividend Date | 08/21/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield